Weichang Chen Selected Research

Weichang Chen Research Topics

Disease

40	Neoplasms (Cancer) 07/2022 - 10/2003
21	Stomach Neoplasms (Stomach Cancer) 02/2022 - 01/2010
14	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 03/2011
13	Carcinogenesis 07/2022 - 03/2011
11	Neoplasm Metastasis (Metastasis) 07/2022 - 03/2011
10	Colonic Neoplasms (Colon Cancer) 09/2021 - 10/2003
4	Colitis 06/2022 - 01/2016
4	Inflammation (Inflammations) 01/2020 - 01/2016
4	Carcinoma (Carcinomatosis) 03/2018 - 01/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2022 - 05/2019
3	Adenocarcinoma 10/2020 - 12/2016
3	Disease Progression 10/2017 - 06/2013
2	Infections 06/2022 - 01/2017
2	Esophageal Squamous Cell Carcinoma 04/2022 - 11/2015
2	Crohn Disease (Crohn's Disease) 12/2021 - 06/2012
2	Pancreatitis 10/2018 - 04/2012
2	Hepatocellular Carcinoma (Hepatoma) 05/2018 - 05/2014
2	Body Weight (Weight, Body) 05/2018 - 01/2015
2	Fibrosis (Cirrhosis) 05/2018 - 01/2015
2	Ulcerative Colitis 09/2017 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2011 - 01/2010
1	Dry Eye Syndromes (Dry Eye Syndrome) 03/2022
1	Thrombocytopenia (Thrombopenia) 03/2022
1	Weight Loss (Weight Reduction) 11/2021
1	Esophageal Neoplasms (Esophageal Cancer) 10/2020
1	Gastroesophageal Reflux (GERD) 10/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2020
1	Gastritis 01/2020
1	Vitamin D Deficiency 05/2019
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Cholangiocarcinoma 01/2019

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2010
10	MicroRNAs (MicroRNA)IBA 06/2021 - 03/2011
9	Biological ProductsIBA 04/2022 - 01/2014
6	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2014
6	CytokinesIBA 06/2022 - 01/2010
6	Therapeutic UsesIBA 08/2017 - 10/2003
4	Messenger RNA (mRNA)IBA 04/2022 - 04/2010
4	Polysaccharides (Glycans)IBA 11/2021 - 01/2016
4	MucinsIBA 01/2020 - 01/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2016 - 09/2009
3	CaspasesIBA 10/2020 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 04/2010
3	Interleukin-6 (Interleukin 6)IBA 09/2020 - 01/2010
3	Small Interfering RNA (siRNA)IBA 03/2018 - 08/2017
3	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 01/2015
2	Circular RNAIBA 07/2022 - 12/2021
2	AutoantibodiesIBA 03/2022 - 01/2019
2	Dextran SulfateIBA 11/2021 - 09/2017
2	Granzymes (Granzyme)IBA 09/2021 - 01/2020
2	Sirtuin 1IBA 08/2021 - 01/2021
2	Cadherins (E-Cadherin)IBA 04/2021 - 05/2016
2	ElementsIBA 09/2020 - 08/2015
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2019
2	Tn antigenIBA 01/2020 - 01/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 01/2011
2	Transcription Factors (Transcription Factor)IBA 10/2018 - 05/2016
2	LuciferasesIBA 01/2018 - 06/2013
2	CateninsIBA 01/2018 - 12/2017
2	Indicators and Reagents (Reagents)IBA 01/2018 - 05/2015
2	Cisplatin (Platino)FDA LinkGeneric 08/2017 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 01/2016
2	4-1BB Ligand (4 1BB Ligand)IBA 06/2015 - 02/2013
2	VaccinesIBA 06/2015 - 02/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2012 - 01/2010
1	CholesterolIBA 07/2022
1	Tumor Biomarkers (Tumor Markers)IBA 07/2022
1	dioscinIBA 06/2022
1	rottlerinIBA 04/2022
1	Carrier Proteins (Binding Protein)IBA 04/2022
1	Insulin-Like PeptidesIBA 04/2022
1	Complement C4 (Complement Component 4)IBA 03/2022
1	Monoclonal AntibodiesIBA 09/2021
1	Immune Checkpoint InhibitorsIBA 09/2021
1	Lactate Dehydrogenase 5IBA 06/2021
1	RNA Splicing FactorsIBA 02/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	SurvivinIBA 10/2020
1	Death Domain ReceptorsIBA 10/2020
1	Caspase 8 (Caspase-8)IBA 10/2020
1	Bile Acids and Salts (Bile Acids)IBA 10/2020
1	perforin-granzyme BIBA 01/2020
1	PerforinIBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	InflammasomesIBA 01/2020
1	Vitamin D FDA LinkGeneric 05/2019
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	N 30IBA 01/2019
1	AntibodiesIBA 01/2019
1	Antinuclear AntibodiesIBA 01/2019
1	TNF Receptor-Associated Factor 3IBA 11/2018
1	Phosphotransferases (Kinase)IBA 10/2018

Therapy/Procedure

5	Therapeutics 02/2021 - 01/2016
4	Immunotherapy 09/2021 - 02/2013
2	Radiotherapy 10/2020 - 10/2017
1	Drug Therapy (Chemotherapy) 01/2021
1	Neoadjuvant Therapy 10/2020
1	Intraperitoneal Injections 01/2020